Although a great deal is known about the details of TCR signaling, how it is initiated continues to be a topic of intense debate. The TCR complex consists of the αβ heterodimer, the associated CD3 chains (dimers of δɛ and γɛ), and the ζ homodimer. The αβ chains engage antigenic peptides bound to the major histocompatibility complex (pMHC), whereas the CD3 and ζ chains function as the signaling components through their immunoreceptor tyrosine-based activation motifs (ITAMs) located in their cytoplasmic domains. The structure of the TCR complex requires that the ligand-binding components somehow communicate to the signaling chains on the cytoplasmic side of the membrane upon appropriate interaction with pMHC.

Many models have been proposed for how TCR signaling is initiated, including TCR oligomerization and conformational change. The oligomerization model has received much support based on the ability of anti-TCR antibodies to cross-link and thereby stimulate T cells ([@bib1]). Furthermore, T cell activation can be mimicked by antibody treatment of chimeric T cell receptors that contain extracellular domains of other molecules linked to CD3 or ζ-containing ITAM sequences, suggesting that clustering of the molecules is sufficient for triggering activation. However, this clustering model does not account for the great sensitivity of the TCR complex. For instance, it has been shown that a small number of peptides, even one pMHC complex, can initiate signaling events ([@bib2]). Under these circumstances, conformational change in the TCR is a more attractive model. Conformational change has also been proposed to explain early studies of TCR signaling where receptor multimerization or the avidity of antibodies for the receptor do not sufficiently explain the biochemical results ([@bib3]). For example, analyses of panels of antibodies against the TCR demonstrated that the ability of the antibody to induce TCR signal transduction or activation was epitope dependent ([@bib4], [@bib5]). Neither avidity nor cross-linking appeared to fully account for the differential stimulatory abilities of the antibodies, thereby lending support for a role for conformational change.

Conformational change within the αβ heterodimer
===============================================

In general, analyses of crystal structures of TCR--pMHC complexes have argued against the idea of a large conformational change within the αβ chains upon ligand engagement. The conformational change that has been deduced from ligand-bound and ligand-free receptors occurs within the complementarity-determining regions (CDRs) of the TCR, which associate with pMHC, but not in the distal portions of the heterodimer which are adjacent to the cell membrane ([@bib6]). The movement in the binding site supports an "induced fit" model of TCR--pMHC engagement where adjustments in the CDR loops are made to accommodate the peptide presented by MHC, but these adjustments do not appear to be transmitted to the associated CD3 and ζ molecules ([@bib6], [@bib7]). However, it is important to note the limitations of the available structural data. Currently, only the ectodomains of the TCR components have been studied in isolation. It is well documented that the transmembrane regions of the TCR are essential for proper TCR assembly ([@bib8]), and thus the CD3 chains may influence or constrain the structural arrangement of the αβ heterodimer. The conformation of the receptor based on crystal structures cannot be appreciated until the entire TCR complex is studied as one functional unit.

Although the majority of the available structural data does not support a conformational change model, recent data complicates the debate. Interestingly, the crystal structure of the LC13 TCR with its ligand, an Epstein-Barr virus peptide--MHC molecule, compared with the unligated receptor, reveals that a large conformational change occurs in the constant domain of TCRα ([@bib9]). However, it is unknown how applicable this structural change is to other TCRs.

Conformational change within the CD3 and ζ chains
=================================================

Despite the relative lack of consistent data regarding conformational change within the αβ heterodimer, there is increasing evidence that conformational change does occur within the associated CD3 chains of the TCR. This idea is intriguing from a signaling perspective because the ITAMs in the cytoplasmic domains of these components are the proximal targets of tyrosine phosphorylation. Once they are doubly phosphorylated by the Src family kinase Lck, the Syk tyrosine kinase ZAP-70 is recruited and then promotes the downstream signaling cascade ([@bib10]). Therefore, alterations in the cytoplasmic tails of the CD3 chains could dramatically affect the availability of the ITAMs and other domains and thus regulate signaling initiation.

The structural regulation of the signaling domains was first proposed for the ζ chain, whose cytoplasmic tail was shown to be differentially available to phosphorylation by Src family kinases based on local environment ([@bib11]). In the presence of lipids, the cytoplasmic domain of the ζ chain was folded and incapable of being phosphorylated, whereas in aqueous solution the domain was unstructured and readily phosphorylated ([Fig. 1](#fig1){ref-type="fig"} A). Although there are no cellular data available supporting these findings, it was suggested that TCR clustering leads to an increase in local ζ concentration and, consequently, competition for membrane binding, thereby resulting in the release of the cytoplasmic domains of ζ from the membrane. The cytoplasmic domains could also be rearranged by some other mechanism that is not clustering dependent as described later.

![Potential mechanism for induced exposure of the proline-rich motif in CD3ɛ. The TCR complex is represented as a tight bundle as suggested by the recent model ([@bib23]). (A) Prior to ligand binding, the cytoplasmic domains of ζ (red chains) could block the motif in CD3ɛ, which would become more accessible upon interaction with pMHC ([@bib11]). (B) Alternatively, movement in CD3ɛ itself could lead to exposure of the proline motif ([@bib12]).](20050179f1){#fig1}

More recently, the conformational change debate has shifted its focus to the cytoplasmic tail of CD3ɛ. In 2002, Alarcón and colleagues reported that upon engagement with certain anti-TCR antibodies or anti-CD3ɛ antibodies the proline-rich sequence in the cytoplasmic tail of CD3ɛ becomes accessible, and this was interpreted to reflect a conformational change (reference [@bib12]; [Fig. 1](#fig1){ref-type="fig"} B). The exposure of the proline-rich sequence was detected by the ability of CD3ɛ to inducibly bind the SH3.1 domain of the adaptor protein Nck. Nck was also recruited to the TCR upon antigen treatment of TCR transgenic T cells. The exposure of the motif occurred independently of and before any tyrosine phosphorylation, thereby suggesting that a TCR conformational change preceded TCR signaling. In addition, lateral movement within membranes was not required since the CD3ɛ proline-rich motif was exposed when cells were stimulated on ice. Perhaps most interestingly, this putative conformational change was not observed with all antibodies used for stimulation. Moreover, a monovalent Fab fragment was able to expose the CD3ɛ motif, suggesting that the TCR cross-linking did not induce the alteration in the cytoplasmic domain. Although their data convincingly demonstrated that the proline-rich sequence is differentially exposed upon ligand treatment, the specific events leading to this accessibility of the CD3ɛ sequence, the role of Nck itself, and the biological relevance of the conformational change remain unclear. Overexpression of the SH3.1 domain of Nck appeared to act as a dominant negative by inhibiting complete TCR activation and proper cytoskeleton rearrangement. But clearly such overexpression is subject to significant artifacts as there may be many targets of this domain, and the binding of this region to the CD3ɛ sequence could disrupt other relevant interactions. Nonetheless, exposure of the motif suggests previously unappreciated movements in the TCR complex.

In this issue, Palmer and colleagues extend the study of CD3ɛ conformational change to murine thymocytes and peptide ligands ([@bib13]). In ex vivo studies of OT-I TCR transgenic CD4^+^ CD8^+^ thymocytes, both positively and negatively selecting peptides expose the proline-rich region in CD3ɛ. The conformational change occurred independently of enzymatic and cellular activity as was seen for Jurkat T cells ([@bib12]). In addition, Gil et al. impressively demonstrate the exposure of the proline-rich region in thymocytes upon engagement with endogenous thymic ligands. Their detailed analysis of the CD3ɛ conformational change in a peptide-dependent manner lends support for a potential role for a conformational change.

The finding that both positively and negatively selecting ligands were capable of equivalently exposing the motif in CD3ɛ indicates that conformational change is not the discriminating factor in selection or for distinguishing agonist from antagonist. However, since peptides that do not function as ligands for the TCR did not induce a conformational change, some productive interaction is required to expose the proline motif. In this way, affinity itself does not appear to be a key factor in mediating conformational change. This is interesting when considering the previous structural studies of the A6 TCR interaction with altered peptide ligands ([@bib14]). Interactions with both weak agonist and antagonists were very similar in structure to that of a strong agonist. These results were interpreted as providing evidence against a conformational change, but that assumed that altered peptide ligands would induce significantly different alterations in structure. Together, the structural and new biochemical data suggest that exposure of the proline motif in CD3ɛ alone is not sufficient for determining qualitative and/or quantitative differences in T cell signaling.

Potential mechanisms for induction of CD3 conformational change
===============================================================

Although there are strong data supporting a conformational change in the CD3 cytoplasmic domains, the question remains how the change occurs upon ligand engagement. As discussed above, with the exception of the LC13 TCR crystal structure, most structural studies do not demonstrate a change in the membrane-proximal regions of the αβ heterodimer ([@bib9]). However, a recent thermodynamic study, where change in heat capacity (a measure of binding energetics) correlates with conformational change or TCR flexibility, supports a role for conformational change ([@bib15]). All but one of the analyzed peptides induced a conformational change in the TCR complex. Interestingly, the combination of half-life and conformational change and/or flexibility best predicted the level of T cell activation. Although the observed changes in heat capacity could be due strictly to changes in CDR3 loops, the recorded conformational change did have an impact on signaling outcome, based on IL-2 production by transgenic TCR T cells, suggesting that the change was somehow transmitted to the CD3 complex or ζ.

One mechanism to explain the alterations in CD3 is the piston model, which has been suggested for the bacterial aspartate receptor ([@bib16]). A similar piston-like movement of the TCR or its rotation could make the cytoplasmic domains of the CD3 chains differentially accessible ([@bib12], [@bib17], [@bib18]). For instance, structural rearrangement of the ζ chain could play a role in rendering the CD3ɛ chain and proline motif more accessible ([@bib11]) ([Fig. 1](#fig1){ref-type="fig"} A). Support for this comes from ζ-deficient mice reconstituted with ζ truncations. Truncation of ζ led to markedly increased phosphorylation of the CD3 chains after receptor stimulation ([@bib19]). There is also some recent data to suggest that ζ may dissociate from the TCR complex or undergo conformational alterations after TCR ligation ([@bib20]). In addition, according to this piston model, the conformational change in the A-B loop of the constant domain of TCRα observed for the LC13 TCR could potentially lead to exposure of the proline-rich region of CD3ɛ ([@bib9]) ([Fig. 1](#fig1){ref-type="fig"} B).

Although the TCR complex is often represented schematically as distinct units, biochemical studies have shown that the chains are associated and functionally coupled by their acidic and basic residue-containing transmembrane domains ([@bib8], [@bib21]). Biochemical studies support three-helix interactions between the transmembrane residues, where TCRα associates with CD3δɛ and the ζ homodimer, whereas TCRβ associates with CD3γɛ, supporting older cross-linking studies ([@bib8], [@bib22]). Recently, the ectodomain structure of the CD3ɛδ was published, thereby completing the structural analysis of the extracellular domains of the TCR complex ([@bib23]). The authors of that study combined all of the available structural information and proposed a model in which the tight transmembrane association is reinforced by conserved ectodomain associations. They further hypothesized that the CD3 subunits sit under the constant domains of the TCR heterodimer loops because the majority of the CD3 dimers are inaccessible ([Fig. 1](#fig1){ref-type="fig"}). If the TCR complex is so tightly associated, it is clearly possible that small alterations that are induced upon ligand binding could be transmitted across the membrane to expose the proline-rich region in CD3ɛ directly or via a ζ conformational change ([Fig. 1](#fig1){ref-type="fig"}).

Conclusion
==========

The recent studies of the TCR complex suggest that ligand-induced conformational change does occur. However, the induction of this conformational change alone is not sufficient for T cell activation. Recent thermodynamic studies and the new study in this issue by Palmer and colleagues suggest that conformational change and other factors can account for signaling initiation and outcome ([@bib13], [@bib15]). Therefore, it remains to be seen how this conformational change contributes to T cell activation. Perhaps the conformational change is a prerequisite for ITAM phosphorylation, and some other unknown factor determines the persistence of phosphorylation and thus signaling potential. Future studies should concentrate on determining the mechanism for CD3ɛ conformational change and elucidating its biological relevance via mutagenesis of the proline-rich sequence.
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